Real-time enrollment status for this recurrent medulloblastoma clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 5:14 PM UTC
| NCT Number | NCT07492316 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Medulloblastoma |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Florida |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 14, 2026: Clinical trial NCT07492316 is currently recruiting participants. This phase1 study for recurrent medulloblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Florida. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07492316 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07492316 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.